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INTRODUCTION
There have been many efforts for the early detection and
management of diabetic nephropathy, which is the leading
cause of end-stage renal disease (ESRD) (1, 2). Microalbumin-
uria is the initial clinical evidence and an increased albumin
excretion rate (AER) is one of the most conventional param-
eters for the progression of diabetic nephropathy (3, 4). Mea-
suring AER as a marker of diabetic nephropathy is based on
the natural history of nephropathy in type 1 diabetes (5-10).
However, in type 2 diabetes, there are many other factors that
can contribute to renal insufficiency without causing albu-
minuria, such as atherosclerosis in renal vasculature, choles-
terol emboli, and interstitial fibrosis (11, 12).
It has been reported that a decline in the renal function of
patients with diabetes is not always accompanied by an in-
creased AER (13, 14). About 20-30% of type 2 diabetics
with renal insufficiency showed normoalbuminuria (12-18).
In the Third National Health and Nutrition Examination
Survey, the prevalence of patients with type 2 diabetes and
renal insufficiency in the absence of both albuminuria and
retinopathy was about 30% (12). Compared with the renal
insufficiency with albuminuria, the patients with normoal-
buminuric renal insufficiency were characterized by female
predominance, older age, higher HDL cholesterol, lower preva-
lence of retinopathy, and possibly better prognosis (15-17).
In addition, compared with diabetic patients with normoal-
buminuria and normal renal function, patients with normoal-
buminuric renal insufficiency had an increased risk of cardio-
vascular disease and metabolic syndrome (18-20). Therefore,
normoalbuminuric renal insufficiency is a distinct entity in
diabetic renal complications. However, the natural course and
pathophysiologic mechanism of normoalbuminuric renal insuf-
ficiency are still elusive.
It has been shown that ESRD accounts for 10-30% of the
deaths in Asian diabetic patients, which clearly contrasts with
a <5-10% risk of renal death in Caucasian diabetic patients
(21). Furthermore, a 4-yr follow up study showed that Asian
diabetic patients are at high risk of progression to ESRD com-
pared with Caucasian diabetic patients (22). These data sug-
gest that Asian patients are more susceptible to diabetic renal
disease compared with Caucasians. In this regard, the clini-
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The Clinical Characteristics of Normoalbuminuric Renal Insufficiency
in Korean Type 2 Diabetic Patients: A Possible Early Stage Renal
Complication
It has been recently reported that a considerable portion of diabetic patients with renal
insufficiency show normoalbuminuria. As little is known about normoalbuminuric
renal insufficiency in the Asian population, we examined its prevalence and clinical
characteristics in Korean type 2 diabetic patients. We studied 562 patients with type
2 diabetes from Seoul National University Hospital. The estimated glomerular filtra-
tion rate (eGFR) was calculated by the Modification of Diet in Renal Disease formu-
la and the degree of albuminuria was evaluated by spot urine albumin-creatinine ratio.
Of 562 patients, 151 (26.9%) patients had renal insufficiency (eGFR <60 mL/min/
1.73m
2). Among them, 44 (29.1%) patients had normoalbuminuria. After excluding
the patients using renin-angiotensin system (RAS) inhibitors, the prevalence of nor-
moalbuminuric renal insufficiency was 35.3% (18 of 51 patients). Compared with micro-
and macroalbuminuric renal insufficiency, normoalbuminuric renal insufficiency was
associated with the female predominance, shorter duration of diabetes, lower preva-
lence of diabetic retinopathy, and lower prevalence of using antihypertensive drugs
except RAS inhibitors. The prevalence decreased progressively with an increase in
the duration of diabetes and an increase in the severity of retinopathy. Normoalbumin-
uric renal insufficiency was prevalent in Korean type 2 diabetic patients. The asso-
ciation with a shorter duration of the diabetes and a lower prevalence of retinopathy
suggests that it might be an early stage renal complication.
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Accepted : 24 December 2008cal characteristics of normoalbuminuric renal insufficiency in
Asian diabetic patients might be different from their Cau-
casian counterparts.
We therefore performed a study on the prevalence and clin-
ical characteristics of Korean type 2 diabetic patients with
normoalbuminuric renal insufficiency and examined its rela-
tions to renin-angiotensin system (RAS) inhibitors, diabetic
retinopathy, and the duration of the diabetes.
MATERIALS AND METHODS
Study population
We studied 562 randomly selected patients from the Dia-
betes Clinic at Seoul National University Hospital from Jan-
uary to December, 2006, who were diagnosed with type 2
diabetes. Excluded from this study were those patients with
anti-GAD antibodies; those who started insulin therapy with-
in the first year after diagnosis; those with a urinary tract infec-
tion, hematuria, or other causes of renal insufficiency; those
with cardiac or hepatic failure; and those with a severe inter-
current illness, including malignancy. The Institutional Review
Board of the Clinical Research Institute in Seoul National
University Hospital approved the study protocol.
Estimation of glomerular filtration rate (GFR)
We calculated the GFR with the Modification of Diet in
Renal Disease (MDRD) formula (23) and defined renal
insufficiency as an estimated GFR (eGFR) of less than 60
mL/min per 1.73 m2 body surface area (BSA), which corre-
sponded to the National Kidney Foundation Kidney Dialysis
Outcomes Quality Initiative guideline (24).
Quantification of albuminuria
We measured the degree of albuminuria with spot tests
of the urine albumin-creatinine ratio (ACR). Urinary albu-
min levels were measured by turbitimer assay (A&T 502X,
A&T, Tokyo, Japan) and urine creatinine levels were mea-
sured by the Jaffe method (Hitachi 7170, Hitachi, Tokyo,
Japan). 
We used sex-specific ACR cut points to define micro- and
macroalbuminuria (25, 26). Microalbuminuria was defined
as an ACR from 17 to 250 μ g/mg for males and from 25 to
355 μ g/mg for females. Macroalbuminuria was defined as an
ACR over 250 μ g/mg and over 355 μ g/mg for males and
females, respectively. Albuminuria denotes the presence of
micro- or macroalbuminuria. 
Assessment of covariates
Questionnaires and review of the patients’ medical records
were used to evaluate the history of stroke, coronary artery
disease, and peripheral vascular disease. Hypertension was
defined as a systolic blood pressure over 140 mmHg or a dias-
tolic blood pressure over 90 mmHg, or the fact that the patient
was taking antihypertensive medications. Drug histories in
relation to anti-hypertensive agents and lipid lowering agents
were also evaluated. Fasting plasma glucose, HbA1c, serum
creatinine, blood urea nitrogen (BUN), serum albumin, total
cholesterol, triglyceride, LDL-cholesterol, and HDL-choles-
terol concentrations were measured. Diabetic retinopathy was
evaluated by direct fundus examination and was graded accord-
ing to the modified Airlie House Classification (27).
Statistical analysis
All continuous variables with normal distributions were
expressed as means±SD, while variables with skewed dis-
tributions were expressed as medians with a range. Variables
not normally distributed were logarithmically transformed
before statistical analysis. The results of categorical data are
expressed as percentages. Student’s t-test and ANOVA were
used to compare the continuous variables between groups and
the chi-square test was used for categorical variables. The p
value for a trend was evaluated by the Mantel-Haenszel chi-
square test. A level of p<0.05 was considered statistically
significant. All data were analyzed using SPSS for Windows
(SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
A total of 562 patients were enrolled in this study. Their
mean age was 59±10 yr; the mean duration of diabetes was
8.0±7.4 yr; and their mean eGFR was 71.3±11.5 mL/min
per 1.73m2. There was a significant inverse correlation between
ACR and eGFR (r=-0.651, p<0.001) (Fig. 1). In the patients
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Fig. 1. Inverse linear relationship between albumin-creatinine ratio
(ACR) and estimated glomerular filtration rate (eGFR).
e
G
F
R
 
(
m
L
/
m
i
n
/
1
.
7
3
 
m
2
)
140
120
100
80
60
40
20
0
10 100 1,000 10,000
ACR (μ g/mg)
r=-0.651
p<0.001with eGFR <60 mL/min/1.73m2, the coefficient of correla-
tion between ACR and eGFR slightly decreased (r=-0.552,
p<0.001).
Among 562 patients, 151 (26.9%) had renal insufficien-
cy, defined as an eGFR <60 mL/min per 1.73 m2. Among
these, the prevalence of normo-, micro-, and macroalbumin-
uric patients was 29.1% (n=44), 33.1% (n=50), and 37.8%
(n=57), respectively. After excluding the patients using RAS
inhibitors (angiotensin converting enzyme inhibitors or ang-
iotensin II receptor blockers), the number of patients with
renal insufficiency was 51 and the prevalence of normo-, micro-,
and macroalbuminuric renal insufficiency was 35.3% (n=18),
41.2% (n=21), and 23.5% (n=12), respectively (Table 1).
The characteristics of the 151 patients with an eGFR <60
mL/min per 1.73 m2 stratified according to their ACR, as
shown in Table 2. Compared with microalbuminuric renal
insufficiency, normoalbuminuric renal insufficiency was asso-
ciated with female predominance, shorter duration of dia-
betes, lower BUN and creatinine, higher eGFR, and lower
HbA1c. In addition, patients with normoalbuminuric renal
insufficiency had a lower prevalence of hypertension and re-
tinopathy, and a lower prevalence of using anti-hypertensive
drugs except RAS inhibitors. Among them, female predom-
inance, lower HbA1c, shorter duration of diabetes, lower preva-
lence of hypertension and retinopathy, and a lower prevalence
of using antihypertensive drugs other than RAS inhibitors
were still significant, even after adjusting for their eGFR. When
the patients using RAS inhibitors were excluded, we obtained
similar results (data not shown). Next, we compared the char-
acteristics of the patients with normoalbuminuric renal insuf-
ficiency with those who had macroalbuminuric renal insuf-
ficiency. The results showed very similar trends to those of
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Data are expressed as n (%).
Normo- Micro- Macro-
albuminuria albuminuria albuminuria
All (n=562) eGFR ≥60 305 (74.2) 96 (23.4) 10 (2.4)
eGFR <60 44 (29.1) 50 (33.1) 57 (37.8)
Without eGFR ≥60 67 (81.7) 15 (18.3) 0 (0.0)
RAS inhibitors eGFR < 60 18 (35.3) 21 (41.2) 12 (23.5)
(n=133)
Table 1. The prevalence of type 2 diabetic patients classified
according to estimated glomerular filtration rate (eGFR) and albu-
min excretion rate (AER) status
Data are means±SD or n (%) unless otherwise indicated. *means p<0.05 vs. the normoalbuminuric group; 
� means p<0.05 vs. the normoalbuminuric
group after exclusion of the patients using renin-angiotensin system inhibitors and after adjustment for GFR. p value
1 means the significance of the dif-
ference between the normo- and micro-albuminuric groups. p value
2 means the significance for the trend that follows the normo-, micro- and macro-
albuminuric groups.
Normo-albuminuria Micro-albuminuria Macro-albuminuria p value
1 p value
2
Number 44 (29) 50 (33) 57 (38)  --
Age (yr) 59±11 57±86 1 ±9 0.94 0.76
Sex (% female) 77 66*
� 42*
� <0.01 <0.01
Duration of diabetes (yr) 5.5±2.3 9.3±3.6*
� 19.5±5.8*
� <0.01 <0.01
Body mass index (kg/m
2) 25.2±2.6 23.9±3.0 24.1±2.8 0.14 0.43
Systolic blood pressure (mmHg) 127±16 130±16 135±15 0.56 0.63
Diastolic blood pressure (mmHg) 72±11 75±11 76±10 0.37 0.47
BUN (mM/L) 6.1±1.4 8.6±1.4* 17.5±8.6* 0.03 0.01
Creatinine (μ M/L) 110±30 130±20* 270±70* 0.04 <0.01
Hemoglobin (g/dL) 14.0±1.4 15.6±1.8 12.0±2.0 0.46 0.62
HbA1c (%) 7.0±1.1 7.9±1.2*
� 7.2±1.2 <0.01 0.85
Cholesterol (mM/L) 4.42±1.03 4.37±0.91 4.60±0.98 0.76 0.74
Triglycerides (mM/L) 1.67±0.94 1.76±0.90 1.75±1.01 0.65 0.69
HDL-Cholesterol (mM/L) 1.19±0.31 1.16±0.28 1.14±0.26 0.53 0.75
LDL-Cholesterol (mM/L) 2.46±0.83 2.38±0.85 2.64±0.67 0.67 0.71
Urine ACR (μ g/mg) 8.5±4.8 116.5±84.3* 2916.9±534.9* <0.01 <0.01
eGFR (mL/min/1.73 m
2) 48.3±5.2 42.2±8.3* 21.4±11.6* 0.03 <0.01
Hypertension, n (%) 16 (36) 26 (52)*
� 51 (89)*
� <0.01 <0.01
Smoking, n (%) 8 (18) 9 (18) 11 (19) 0.78 0.83
Retinopathy, n (%) 7 (15) 28 (56)*
� 46 (81)*
� <0.01 <0.01
Coronary artery disease, n (%) 8 (18) 10 (20) 18 (32) 0.78 0.43
Cerebrovascular disease, n (%) 3 (7) 6 (12) 7 (12) 0.73 0.82
Peripheral vascular disease, n (%) 1 (2) 2 (4) 3 (5) 0.50 0.46
RAS inhibitors, n (%) 26 (47) 29 (55) 45 (68) 0.65 0.37
Other antihypertensive drugs, n (%) 5 (11) 20 (40)*
� 47 (82)*
� <0.01 <0.01
Statins, n (%) 17 (39) 29 (58) 38 (67) 0.37 0.18
Table 2. Clinical and laboratory characteristics of type 2 diabetic patients with renal insufficiency according to albumin excretion ratio
(AER) statusthe comparison between normo- and microalbuminuric renal
insufficiency, except for HbA1c, which was comparable between
the two groups. Finally, we found that female predominance,
shorter duration of diabetes, lower prevalence of hypertension
and retinopathy, and a lower prevalence of using antihyper-
tensive drugs except RAS inhibitors showed significant trends
across the degree of albuminuria. 
Table 3 compares the clinical characteristics of 349 patients
with normoalbuminuria according to their eGFR. The patients
with normoalbuminuric renal insufficiency (n=44, 12.6%)
were older, more likely to be female, had a higher prevalence
of using RAS inhibitors and statins, and a higher prevalence
of coronary artery disease. The patients with normoalbumin-
uric renal insufficiency, who were not taking RAS inhibitors
or statins, showed similar results but they additionally showed
higher triglyceride levels (1.83 [0.59-8.20] vs. 1.69 [0.65-
6.53] mM/L, p=0.03; expressed as a median [range]) and lower
HDL-cholesterol levels (1.01±0.23 vs. 1.24±0.28 mM/L,
p=0.02) compared to their counterparts with normal renal
function.
We evaluated the trend of changes in the prevalence of
normo-, micro-, and macroalbuminuric renal insufficiency
along with the duration of the diabetes. The prevalence of
normoalbuminuria decreased progressively, whereas the preva-
lence of macroalbuminuria increased with an increase in the
duration of diabetes (Mantel-Haenszel  2 test, p for trend
<0.001) (Fig. 2).
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Data are means±SD or n (%) unless otherwise indicated. *means p<0.05 after exclusion of the patients using renin-angiotensin system inhibitors and
statins.
eGFR ≥60 eGFR <60 p value
Number 305 44  -
Age (yr) 51±75 9 ±11 0.04*
Sex (% Female) 47 76  <0.01*
Duration of diabetes (yr) 5.7±2.8 5.5±2.3 0.65
Body mass index (kg/m
2) 24.1±3.1 25.2±2.6 0.14
Systolic blood pressure (mmHg) 119±18 127±16 0.25
Diastolic blood pressure (mmHg) 75±12 72±11 0.57
BUN (mM/L)  5.4±1.4 6.1±1.4 <0.01
Creatinine (μ M/L) 80±20 110±30 <0.01
Hemoglobin (g/dL)  14.1±1.5 14.0±1.4 0.57
HbA1c (%) 7.2±1.4 7.0±1.1 0.65
Cholesterol (mM/L)  4.78±1.06 4.42±1.03 0.11
Triglycerides (mM/L) 1.71±1.09 1.67±0.94 0.48*
HDL-Cholesterol (mM/L) 1.27±0.28 1.19±0.31 0.09*
LDL-Cholesterol (mM/L) 2.72±0.96 2.48±0.83 0.25
Urine ACR (μ g/mg) 8.4±5.1 8.5±4.8 0.79
eGFR (mL/min/1.73 m
2) 75.3±9.8 48.3±5.2 <0.01
Hypertension, n (%)  101 (33) 16 (36) 0.21
Smoking, n (%)  40 (13) 8 (18) 0.14
Retinopathy, n (%)  34 (11) 7 (15) 0.23
Coronary artery disease, n (%) 27 (9) 8 (18) 0.02*
Cerebrovascular disease, n (%) 6 (2) 3 (7) 0.12
Peripheral vascular disease, n (%) 3 (1) 1 (2) 0.87
RAS inhibitors, n (%) 55 (18) 26 (47) <0.01
Other antihypertensive drugs, n (%) 37 (12) 11 (25) 0.15
Statins, n (%) 40 (13) 17 (39) <0.01
Table 3. Clinical and laboratory characteristics of type 2 diabetic patients with normoalbuminuria according to eGFR
Fig. 2. The relationship between the degree of urinary albumin excre-
tion and the duration of diabetes in type 2 diabetic patients with renal
insufficiency. p for trend <0.001 by Mantel-Haenszel 
2 test.
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macroalbuminuria microalbuminuria normoalbuminuriaTable 4 shows the prevalence of the respective grade of re-
tinopathy according to the AER status of the patients with
renal insufficiency. The retinopathy and albuminuria were
both absent in 37 of the 151 (24.5%) patients. In the nor-
moalbuminuric renal insufficiency group, most of the patients
(37 of 44 patients, 84.1%) had no retinopathy. The prevalence
and severity of retinopathy were markedly and progressively
increased in the micro- and macroalbuminuria groups (Man-
tel-Haenszel chi-square test, p for trend <0.001).
DISCUSSION
Among the Korean patients with type 2 diabetes and renal
insufficiency, the prevalence of normoalbuminuria was 29.1%
(35.3% in those not using RAS inhibitors). Even after adjust-
ing for their eGFR, normoalbuminuric renal insufficiency was
associated with female predominance, lower HbA1c, short-
er duration of diabetes, lower prevalence of hypertension and
retinopathy, and a lower prevalence of using antihypertensive
drugs except RAS inhibitors compared with microalbumin-
uric renal insufficiency. These results are largely similar to
those from Caucasian studies (15-17). The characteristics of
a shorter duration of the diabetes and a lower prevalence of
retinopathy found in this study suggest that normoalbumin-
uric renal insufficiency might be an earlier stage of renal insuf-
ficiency compared with microalbuminuric renal insufficien-
cy. This is further supported by the results that the prevalence
of normoalbuminuric renal insufficiency decreased with an
increase in the duration of the diabetes and with the advanced
stage of retinopathy. Thus, it might be speculated that some
type 2 diabetic patients might face renal insufficiency with-
out albuminuria and may then progress to microalbuminuric
and macroalbuminuric renal insufficiency as the duration of
type 2 diabetes increases. However, there are reports showing
that normoalbuminuric renal insufficiency was not associat-
ed with a lower prevalence of retinopathy (15, 16). Further-
more, Rigalleau et al. (17) reported that diabetic patients with
normoalbuminuric renal insufficiency showed stable AER over
38 months and had a low risk for the progression to ESRD
or death. Therefore, to support our hypothesis that normoal-
buminuric renal insufficiency might be an earlier stage of dia-
betic renal complication, we need a prospective study includ-
ing looking into the change of renal pathology.
In the next step, we examined whether there was any dif-
ference in the clinical characteristics of normoalbuminuric
patients according to their eGFR. Compared with the patients
with normoalbuminuria in the absence of renal insufficiency,
those with normoalbuminuric renal insufficiency were older,
more likely to be female, had a higher prevalence of using
RAS inhibitors and statins, and a higher prevalence of coro-
nary artery disease. The higher prevalence of coronary artery
disease suggests that other atherosclerotic diseases involving
the renal vasculature might be responsible for the decreased
renal function in the absence of albuminuria. In this regard,
a recent report (18) also showed that normoalbuminuric renal
insufficiency was associated with metabolic syndrome. How-
ever, MacIsaac et al. (16) found that patients with type 2 dia-
betes and reduced GFR had similar degrees of intrarenal vas-
cular disease, assessed by the intrarenal arterial resistance index.
Therefore, at this time, the mechanism of normoalbuminuric
renal insufficiency still remains elusive. Interestingly, genetic
susceptibility might play a role in the development of nor-
moalbuminuric renal insufficiency. It has been reported that
polymorphisms of the protein kinase C-βgene (PRKCB1)
were associated with diabetic nephropathy that did not lead
to albuminuria in Japanese patients (28).
A female predilection for normoalbuminuric renal insuf-
ficiency has been noted in many other previous studies (14,
15, 17, 18), but the reason for this association is unknown.
In this study, the patients with normoalbuminuric renal insuf-
ficiency were more likely to be females over 50 (odds ratio
[OR] and 95% confidence interval [CI] was 3.08 [1.15-4.13],
p=0.017), while we could not find this age effect in male sub-
jects (OR and 95% CI was 1.38 [0.48-3.26], p=0.646) (data
not shown in the Results). Therefore, the pathogenesis of
normoalbuminuric renal insufficiency might be affected by
the hormonal change that occurs around menopause.
There were several limitations in this study. First, owing
to the cross-sectional design it was difficult to clarify the
causal relationship between the risk factors and the natural
course of the normoalbuminuric renal insufficiency. Second,
the eGFR might not reflect the actual GFR of our study
population, since the MDRD study included very few Asians
(29). Third, the assessment of AER with a single specimen
might not exactly estimate the number of normoalbumin-
uric renal insufficiency. Finally, the number of the patients
with renal insufficiency not taking RAS inhibitors was some-
what small. Therefore, a further study including sufficient
number of patients in this category is necessary.
In conclusion, normoalbuminuric renal insufficiency was
prevalent in type 2 diabetic Korean patients and the clinical
characteristics were largely similar to those seen in previous
studies. The association with a shorter duration of the diabetes
and a lower prevalence of retinopathy suggests that normoal-
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Data are expressed as n (%). p for trend <0.001 by Mantel-Haenszel
chi-square test.
Normo- Micro- Macro-
albuminuria albuminuria albuminuria
No retinopathy 37 (84.1) 22 (44.0) 11 (19.3)
Non-proliferative, mild 5 (11.3) 10 (20.0) 7 (12.3)
Non-proliferative, moderate 1 (2.3) 7 (14.0) 9 (15.8)
Non-proliferative, severe 1 (2.3) 5 (10.0) 11 (19.3)
Proliferative 0 (0) 6 (12.0) 19 (33.3)
Table 4. The prevalence of retinopathy in type 2 diabetic patients
with renal insufficiencybuminuric renal insufficiency might be an early stage renal
complication in Korean type 2 diabetic patients. 
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